Cite

    Liou, J. et al. (2018). 14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial. Journal of antimicrobial chemotherapy. pp. 2510-2518. [Online].